(19)
(11) EP 3 941 586 A1

(12)

(43) Date of publication:
26.01.2022 Bulletin 2022/04

(21) Application number: 20773768.5

(22) Date of filing: 20.03.2020
(51) International Patent Classification (IPC): 
A61P 31/04(2006.01)
C07D 277/64(2006.01)
C07C 279/12(2006.01)
(52) Cooperative Patent Classification (CPC):
C07D 213/82; C07C 2601/08; C07D 213/68; C07D 239/34; C07C 279/24; C07B 2200/07; C07D 261/12; C07C 279/28; C07C 279/12; A61P 31/04
(86) International application number:
PCT/US2020/023994
(87) International publication number:
WO 2020/191348 (24.09.2020 Gazette 2020/39)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 21.03.2019 US 201962821926 P

(71) Applicant: Cortexyme, Inc.
South San Francisco, CA 94080 (US)

(72) Inventors:
  • GALEMMO JR., Robert A.
    San Francisco, California 94080 (US)
  • KONRADI, Andrei W.
    San Francisco, California 94080 (US)
  • LYNCH, Casey C.
    San Francisco, California 94080 (US)
  • DOMINY, Stephen S.
    San Francisco, California 94080 (US)

(74) Representative: J A Kemp LLP 
80 Turnmill Street
London EC1M 5QU
London EC1M 5QU (GB)

   


(54) ARGININE GINGIPAIN INHIBITORS